7-128855315-G-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001458.5(FLNC):c.7251+1G>T variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000689 in 1,451,048 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_001458.5 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FLNC | NM_001458.5 | c.7251+1G>T | splice_donor_variant, intron_variant | ENST00000325888.13 | NP_001449.3 | |||
FLNC | NM_001127487.2 | c.7152+1G>T | splice_donor_variant, intron_variant | NP_001120959.1 | ||||
FLNC-AS1 | NR_149055.1 | n.103-1918C>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FLNC | ENST00000325888.13 | c.7251+1G>T | splice_donor_variant, intron_variant | 1 | NM_001458.5 | ENSP00000327145.8 | ||||
FLNC | ENST00000346177.6 | c.7152+1G>T | splice_donor_variant, intron_variant | 1 | ENSP00000344002.6 | |||||
FLNC-AS1 | ENST00000469965.1 | n.103-1918C>A | intron_variant | 4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.89e-7 AC: 1AN: 1451048Hom.: 0 Cov.: 29 AF XY: 0.00000138 AC XY: 1AN XY: 722674
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Myofibrillar myopathy 5;C3279722:Distal myopathy with posterior leg and anterior hand involvement;C4310749:Hypertrophic cardiomyopathy 26;CN239310:Dilated Cardiomyopathy, Dominant Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 09, 2020 | This sequence change affects a donor splice site in intron 43 of the FLNC gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in FLNC are known to be pathogenic (PMID: 27908349). Experimental studies have shown that a different nucleotide change at this splice site disrupts mRNA splicing (PMID: 28008423). Disruption of this splice site has been observed in individual(s) with dilated cardiomyopathy (PMID: 27908349, 28008423). This variant is not present in population databases (ExAC no frequency). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at